News

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Tamei Elliott,Senior Manager, Scientific Programs, Drug Information Association, discusses changes to the role of diversity in clinical trials in regard to scientific programing.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses the near-term and long-term future of SMART on FHIR.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses the current state of SMART on FHIR and its impact on the usefulness of real-world data.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses his passion for SMART on FHIR.

Integrated eCOA & ePRO solution taps company’s technology expertise.

DIA session offers an overview of the current regulatory landscape and challenges for both sponsors and regulators in achieving quality and integrity in the fast-moving area.

Collaboration to focus on digital vascular biomarker patient monitoring trial.

First guidance in this area from the Agency addresses the unique challenges when designing clinical studies for these drugs

ICH unveils new draft guidance on good clinical practice, with the aim of aligning trial conduct with advancing life sciences innovation and technology.

Addition solidifies commitment to delivering comprehensive solutions worldwide, company says.

Suite of AI-enhanced SaaS solutions address many functions within clinical development.

FDA’s new voluntary pilot program is designed to help clinicians select appropriate cancer treatments for patients.

New partnership brings 15,000 members to participate in AOD membership.

Virtual CRO seeks to help life sciences companies meet new federal guidelines for diversity, equity, and inclusion in clinical trials.

Expansion into UK marks company’s third international subsidiary.

Latest number of infectious disease clinical trials from ClinicalTrials.gov.

New toolkit to standardize guidelines for streamlined IRB/Ethics review of DCT applications.

With 10 mobile community research sites in the US, the move expands the organization’s international reach.

Compl-AI©™ aims to predict the risk of patient nonadherence and dropout.

The latest people and business news from the past month, all in one place.

Relationship seeks to advance Freenome's multi-cancer research program.

Contest is part of a community engagement program seeking to connect the arts, sciences, and community in support of clinical trial participation.

The EU has launched a public consultation on balancing the transparency of study information with confidentiality concerns.

AI-powered platform will allow clinical trial sites to connect directly with patient EHRs.

AARDEX MEMS AS and MEMS Mobile technology will be integrated with Mevia’s Medose dispenser.

DIA President and Global Chief Executive provides the highlights for this year’s meeting being held in Boston at the end of June.

First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.

Software and biometrics services provider announces expanded AI and ML capabilities.

Newly released book edited by Matt Reaney, (PhD, CPsychol, CSci, MSc), head, science and analytics, PCS, at IQVIA focuses on patient experience data with all levels of clinical research in mind.

Veeva R&D Business Consulting will provide operating model design, data governance, and change management services.